Literature DB >> 26719444

Plasmalyte: No Longer a Culprit in Causing False-Positive Galactomannan Test Results.

Isabel Spriet1, Katrien Lagrou2, Johan Maertens3, Ludo Willems4, Alexander Wilmer5, Joost Wauters5.   

Abstract

False-positive galactomannan (GM) results have been reported in patients treated with gluconate-containing solutions, such as Plasmalyte. The GM optical density index was tested on 33 distinct batches of Plasmalyte and was found to be negative in all of the batches, confirming that Plasmalyte is no longer a cause of false-positive GM results.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26719444      PMCID： PMC4767971          DOI： 10.1128/JCM.02813-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies.

Authors:  Olivier Adam; Anne Aupérin; Fanny Wilquin; Jean-Henri Bourhis; Bertrand Gachot; Elisabeth Chachaty
Journal:  Clin Infect Dis       Date:  2004-02-27       Impact factor: 9.079

2.  Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid.

Authors:  Chadi A Hage; John M Reynolds; Michelle Durkin; L Joseph Wheat; Kenneth S Knox
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

3.  Gluconate-containing intravenous solutions: another cause of false-positive galactomannan assay reactivity.

Authors:  Ignace Surmont; Willem Stockman
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

4.  Gluconic acid production by Aspergillus terreus.

Authors:  C Dowdells; R L Jones; M Mattey; M Bencina; M Legisa; D M Mousdale
Journal:  Lett Appl Microbiol       Date:  2010-06-17       Impact factor: 2.858

Review 5.  Fluid use in adult intensive care.

Authors:  Maria Wujtewicz
Journal:  Anaesthesiol Intensive Ther       Date:  2012-08-08

6.  Galactomannan antigenemia after infusion of gluconate-containing Plasma-Lyte.

Authors:  Ruta Petraitiene; Vidmantas Petraitis; John R Witt; Michelle M Durkin; John D Bacher; L Joseph Wheat; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

Review 7.  Choice of fluid in acute illness: what should be given? An international consensus.

Authors:  K Raghunathan; P T Murray; W S Beattie; D N Lobo; J Myburgh; R Sladen; J A Kellum; M G Mythen; A D Shaw
Journal:  Br J Anaesth       Date:  2014-11       Impact factor: 9.166

8.  False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.

Authors:  Claudio Viscoli; Marco Machetti; Paola Cappellano; Barbara Bucci; Paolo Bruzzi; Maria Teresa Van Lint; Andrea Bacigalupo
Journal:  Clin Infect Dis       Date:  2004-02-27       Impact factor: 9.079

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 10.  Biotechnological production of gluconic acid: future implications.

Authors:  Om V Singh; Raj Kumar
Journal:  Appl Microbiol Biotechnol       Date:  2007-02-14       Impact factor: 4.813
View more
  4 in total

1.  Challenges with Utilizing the 1,3-Beta-d-Glucan and Galactomannan Assays To Diagnose Invasive Mold Infections in Immunocompromised Children.

Authors:  Alice J Hsu; Pranita D Tamma; Sean X Zhang
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

2.  Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.

Authors:  Koen de Heer; Marije G Gerritsen; Caroline E Visser; Mariska Mg Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2019-05-20

3.  Plasma-Lyte 148: A clinical review.

Authors:  Laurence Weinberg; Neil Collins; Kiara Van Mourik; Chong Tan; Rinaldo Bellomo
Journal:  World J Crit Care Med       Date:  2016-11-04

4.  Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Chadi A Hage; Eva M Carmona; Oleg Epelbaum; Scott E Evans; Luke M Gabe; Qusay Haydour; Kenneth S Knox; Jay K Kolls; M Hassan Murad; Nancy L Wengenack; Andrew H Limper
Journal:  Am J Respir Crit Care Med       Date:  2019-09-01       Impact factor: 21.405
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.